Skip to content

Comparison of Nigella sativa oill and Vitex agnus on breast pain

Effect of Nigella sativa oill and Vitex agnus on severity mastalgia during pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201104304785N3
Enrollment
108
Registered
2015-02-02
Start date
2014-08-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communication of Nigella sativa oill and Vitex agnus on severity mastalgia durig the female reproductive..

Interventions

Intervention 1: Black Seed is one of the intervention groups. Intervention 2: The second intervention group is taking Vitex agnus. Intervention 3: The third group is the Placebo.
Treatment - Drugs
Black Seed is one of the intervention groups
The second intervention group is taking Vitex agnus.
The third group is the Placebo

Sponsors

Tehran University of Medical Siences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 49 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women who have literacy; women who are between 49-15 years; women who have cyclic mastalgia; women have not with suspicious lesions or ulcers on ultrasound or mammography over the last year; visual pain scale score (vas) is more than3; women have not with a history of breast surgery; women experience physical and mental illness are not known; women who not use of any medication such as analgesics, anti-inflammatory drugs and other treatments for mastalgia during the last two months; women who do not Addiction to drugs; women who do not consume alcohol; women who do not smoke. Exclusion Criteria: women with mastalgia who are allergic to medications; women with mastalgia who are not willing to continue to work and are not taking drug; women do not have medication during every month for more than 2 days and 4 days of intermittent; women who become pregnant during the study; Women who need to take painkillers regularly.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity mastalgia. Timepoint: 2 months before the intervention, and 3 months after intervention. Method of measurement: Visual analog pain scale and McGill questionnaire.

Secondary

MeasureTime frame
Black Seed Oil impact of the intervention group. Timepoint: 3 months after intervention. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmeneh Sotoodeh Moridani

Tehran University of Medical Sciences

Amanehsotodeh9@yahoo.com+98 21 8892 3198

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026